LB Pharmaceuticals Inc
LBRX
$15.51
-$0.69-4.26%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/6/2025
-
The Fly
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/3/2025
-
MarketBeat
10/14/2025
-
GuruFocus
10/14/2025
-
The Fly
10/14/2025
-
Globe Newswire
10/14/2025
-
MarketBeat
10/10/2025
-
MarketBeat
10/10/2025
-
MarketBeat
10/8/2025
-
MarketBeat
10/7/2025
-
MarketBeat
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
The Fly
10/6/2025
-
Globe Newswire
10/6/2025
-
GuruFocus
10/6/2025
-
MarketBeat
10/6/2025
-
The Fly
10/6/2025
-
The Fly
10/6/2025
-
The Fly
9/27/2025
-
24/7 Wall St.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, August 22, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Aug 17 and 21 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 605 0300
Address
One Pennsylvania Plaza
New York, NY 10119
New York, NY 10119
Country
Year Founded
Business Description
Sector
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead...
more